Cromos™ Pharma is a premier regional CRO with operations in Central and Eastern Europe, former Soviet Republics and Israel
Cromos™ Pharma is a regional contract research organization (CRO) that specializes in biopharmaceutical clinical monitoring & outsourcing to Geоrgia, Belarus, Russia, Ukraine, Baltic States, countries of Eastern Europe and Israel. The company manages Phase I-IV clinical trials, bioequivalence and observational studies and has been successfully operating since 2004.
Our business model is a product of the most validated Western solutions which are carefully tailored to local environments monitoring
Full compliance with ICH GCP regulations, motivated and experienced investigators with impeccable reputations, large patient population is the integral to our ability to provide high quality and affordable services.
As project managers, our "summa cum laude" MDs and PhDs don't just flawlessly adhere to a study protocol, they appreciate the science behind it. By choosing Cromos™ Pharma you get an invariable guarantee that your project will be handled by the "A-team".
In 2012 Cromos™ Pharma has adopted a fully integrated, cloud-based, virtual workplace model. This has allowed for seamless integration of all offices and employees, significantly increased the company's productivity and reduced its overhead.
Cromos™ Pharma's industry-leading risk-sharing clinical development platform differentiates us from the competition. It offers biotech, pharma and device companies that have promising drug, biologics or medical device technologies several unique business partnership algorithms, including clinical research program conduct in exchange for equity or licensing opportunities. We invite interested pharmaceutical, biotech, and medical device companies to reach out to us for an in depth evaluation of potential strategic partnerships.
Please, contact us to learn more about Cromos™ Pharma clinical trials services.
Cromos™ Pharma launches risk-sharing partnerships program with biotech and pharma companies / 15.12.2014
Cromos™ Pharma launches Corium Research, a premier dermatology site research organization / 18.11.2014
Cromos™ Pharma at New York CEO Conference / 07.10.2014
Cromos™ Pharma CEO, Dr. Bogin, will be presenting at MAGI Clinical Research Conference that takes place in San Francisco on November 9-12, 2014 / 07.10.2014